Lymph node biopsy results for desmoplastic malignant melanoma

Cutis

Volumn 79, Issue 5, 2007, Pages 390-394

  Cummins, Deborah L ^a,b   Esche, Clemens ^a   Barrett, Terry L ^a   Balch, Charles M ^a   Mofid, Mona ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MEDICAL RECORD; MELANOMA; METASTASIS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MARYLAND; MEDICAL RECORDS; MELANOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 34250625762     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Conley J, Lattes R, Orr W. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer. 1971;28:914-936.
2. Carlson JA, Egbert BM. Desmoplastic neurotropic malignant melanoma. Pathology. 1994;2:339-357.
3. Payne WG, Kearney R, Wells K, et al. Desmoplastic melanoma. Am Surg. 2001;67:1004-1006.
4. Jaroszewski DE, Pockaj BA, DiCaudo DJ, et al. The clinical behavior of desmoplastic melanoma. Am J Surg. 2001;182:590-595.
5. Quinn MJ, Crotty KA, Thompson JF, et al. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer. 1998;83:1128-1135.
6. Skelton HO, Smith KJ, Laskin WB, et al. Desmoplastic malignant melanoma. J Am Acad Dermatol. 1995;32: 717-725.
7. Jain S, Allen PW. Desmoplastic malignant melanoma and its variants, a study of 45 cases. Am J Surg Pathol. 1989;13:358-373.
8. Perrott RE, Glass LF, Reintgen DS, et al. Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma. J Am Acad Dermatol. 2003;49: 567-588.
9. Houghton A, Coit D, Bloomer W, et al. NCCN melanoma practice guidelines. National Comprehensive Cancer Network. Oncology (Williston Park). 1998;12:153-177.
10. Gyorki DE, Busam K, Panageas K, et al. Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma. Ann Surg Oncol. 2003;10:403-407.
11. Su LD, Fullen DR, Lowe L, et al. Desmoplastic and neurotropic melanoma. Cancer. 2004;100:598-604.
12. Thelmo MC, Sagebiel RW, Treseler PA, et al. Evaluation of sentinel lymph node status in spindle cell melanomas. J Am Acad Dermatol. 2001;44:451-455.
13. Lens MB, Newton-Bishop JA, Boon AP. Desmoplastic malignant melanoma: a systematic review. Br J Dermatol. 2005;152:673-678.
14. Zapas JL, Coley HC, Beam SL, et al. The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy. J Am Coll Surg. 2003; 197: 403-407.
15. Dessureault S, Soong SJ, Ross MI, et al, for the American Joint Committee on Cancer (AJCC) Melanoma Staging Committee. Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol. 2001;8: 766-770.
16. Wagner JD, Evdokimow DZ, Weisberger E, et al. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol. 2004;140:75-79.
17. Livestro DP, Muzikansky A, Kaine EM, et al. Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol. 2005;23: 6739-6746.